Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Oral iron supplements for children in malaria-endemic areas
Ami Neuberger
, Joseph Okebe
,
Dafna Yahav
, Mical Paul
*
*
Corresponding author for this work
Technion-Israel Institute of Technology
Medical Research Council Laboratories Gambia
Rabin Medical Center Israel
Rambam Health Care Campus Israel
Research output
:
Contribution to journal
›
Review article
›
peer-review
100
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Oral iron supplements for children in malaria-endemic areas'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
18 Years Old
16%
Adjusted Analysis
16%
Anemia
83%
Antihelminthic
16%
Antimalarial Activity
33%
Assessment Approach
16%
Assessment Development
16%
Clinical Malaria
100%
Cluster Randomized Trial
33%
Cochrane
16%
Cochrane Central Register of Controlled Trials
16%
Cochrane Library
16%
Confidence Interval
83%
Development Approach
16%
Disease Groups
16%
Domain-independent
16%
Evaluation Approach
16%
Evaluation Assessment
16%
Event Rate
16%
Fixed Effects
16%
Folic Acid
66%
Grading of Recommendations
16%
Hemoglobin
16%
Hyperendemic
33%
Inclusion Criteria
16%
Infectious Diseases
16%
International Clinical Trials Registry Platform (ICTRP)
16%
Iron Administration
16%
Iron Deficiency
16%
Iron Deficiency Anemia
16%
Iron Fortification
16%
Iron Supplementation
50%
Iron Treatment
33%
Malaria
83%
Malaria Endemic Areas
100%
Malaria Management
50%
Malaria Prevention
50%
Malaria Risk
66%
Malaria Transmission
16%
Management Services
66%
MEDLINE
16%
Meta-analysis
33%
Micronutrients
16%
Ongoing Trials
16%
Oral Iron Supplements
100%
Orally Administered
16%
Outcome Analysis
16%
Outcome Effect
16%
Placebo
16%
Preventive Health Services
66%
Random-effects Meta-analysis
16%
Randomized Controlled Trial
16%
Rate 1
16%
Recommended Dietary Allowance
16%
Risk of Bias
16%
Risk Ratio
83%
Search Methods
16%
Selection Criteria
16%
Severe Malaria
33%
Subgroup Analysis
16%
World Health Organization
16%
Medicine and Dentistry
Anemia
33%
Anthelmintic Agent
6%
Antimalarial
13%
Attributable Risk
6%
Base
6%
Clinical Trial
6%
Dietary Reference Intake
6%
Folic Acid
26%
Holoendemic
13%
Hypochromic Anemia
6%
Infectious Disease
6%
Iron
100%
Iron Deficiency
6%
Iron Supplement
100%
Malaria Control
20%
Meta-Analysis
20%
Placebo
6%
Randomized Controlled Trial
20%
Subgroup Analysis
6%
Supplementation
20%
Trace Element
6%
Pharmacology, Toxicology and Pharmaceutical Science
Anemia
29%
Anthelmintic Agent
5%
Antimalarial Agent
11%
Base
5%
Clinical Trial
5%
Diseases
5%
Folic Acid
23%
Iron
100%
Iron Deficiency
5%
Iron Deficiency Anemia
5%
Placebo
5%
Randomized Controlled Trial
17%
Trace Element
5%